StockData
Enlivex Ltd. logo

Enlivex Ltd. (ENLV) stock

ENLVNasdaqFinance ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 25, 2026Score 6/30
$1.15+0.03 (+2.68%)

Close on Nov 17, 2026Market cap $19.36MP/E 0.0Yield –

Enlivex r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $9.20M, down 13.4% from the year before. Over ten years it grew 1.8% a year on average. The highest annual figure on record is $19.01M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.20M-13.4%
FY2024Dec 31, 2024$10.62M-44.1%
FY2023Dec 31, 2023$19.01M+1.7%
FY2022Dec 31, 2022$18.69M+45.1%
FY2021Dec 31, 2021$12.88M+111.6%
FY2020Dec 31, 2020$6.09M+8.6%
FY2019Dec 31, 2019$5.60M+39.6%
FY2018Dec 31, 2018$4.01M+137.3%
FY2017Dec 31, 2017$1.69M-81.0%
FY2016Dec 31, 2016$8.88M+15.4%
FY2015Dec 31, 2015$7.69M+73.2%
FY2014Dec 31, 2014$4.44M+506.7%
FY2013Dec 31, 2013$732.00K+422.9%
FY2012Dec 31, 2012$140.00K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.92M-28.9%
Q2 FY2025Jun 30, 2025$2.14M-15.7%
Q2 FY2024Jun 30, 2024$2.00M+59.0%
Q2 FY2023Jun 30, 2023$5.04M+623.4%
Q2 FY2022Jun 30, 2022$4.11M–
Q2 FY2021Jun 30, 2021$2.54M–
Q2 FY2020Jun 30, 2020$1.26M–
Q2 FY2019Jun 30, 2019$696.00K–

More Enlivex figures

See a number that looks wrong?